We came across a bullish thesis on Intuitive Surgical, Inc. on Uncle Stock Notes’s Substack. In this article, we will ...

Intuitive Surgical (NasdaqGS:ISRG) received FDA clearance for its da Vinci 5 system to be used in certain cardiac procedures.

Intuitive Surgical's 2025 earnings were strong, and the future remains bright, with valuation as the only big concern for investors.

Artificial intelligence isn't performing surgery yet, but if (when?) it does, these two companies are likely to be at the ...

If you are wondering whether Intuitive Surgical at around US$525 a share still makes sense for your portfolio, the key ...

With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S ...

Medtronic's Hugo robotic surgery system has been approved in the U.S. for urologic procedures. The company is also a leader ...

The robotics giant revealed on an earnings call that it won FDA clearance for several cardiac procedures and is also ramping up its presence in ambulatory surgery centers.

Investing.com -- TD Cowen initiated coverage of Intuitive Surgical with a Buy rating and a $660 price target, saying the launch of the da Vinci 5 system is driving a long-tailed product cycle that can ...

Intuitive Surgical (NASDAQ: ISRG) reports in-line Q4 results, sets measured guidance for 2026, with an 18% revenue growth and ...

Intuitive Surgical is selling an increasing number of da Vinci surgical robots. The number of procedures performed with a da Vinci robot is rising rapidly. The flywheel of Intuitive Surgical's ...